Position in LLY
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$65,177,031
+$15,480,019 QoQ
Shares Held
54,340
+0.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
2.74%
of 13F equity value
Holder Rank
#478
of 4,604 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTHEAST INVESTMENT MANAGEMENT holds $126,194,934 across 8 Drug Manufacturers - General names. LLY ranks #1 (51.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
54,340 | $65,177,031 | |
| 2 | JNJ |
Johnson & Johnson
|
170,118 | $43,204,868 | |
| 3 | MRK |
Merck & Co., Inc.
|
57,478 | $7,385,923 | |
| 4 | NVS |
Novartis AG
|
27,819 | $4,359,793 | |
| 5 | ABBV |
AbbVie Inc.
|
12,037 | $3,028,990 | |
| 6 | AMGN |
Amgen Inc
|
4,802 | $1,738,900 | |
| 7 | PFE |
Pfizer Inc
|
38,632 | $930,258 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,407 | $369,171 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,177,031 | 54,340 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $49,697,012 | 54,032 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $58,060,667 | 54,026 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $41,310,346 | 54,142 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $42,574,030 | 54,615 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $45,805,794 | 55,461 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $41,285,016 | 53,478 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $45,406,196 | 51,252 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $45,698,150 | 50,474 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $36,309,727 | 46,673 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $24,081,591 | 41,312 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $19,201,860 | 35,749 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $13,929,174 | 29,701 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $5,858,058 | 17,058 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $5,883,804 | 16,083 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $4,789,136 | 14,811 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $4,352,139 | 13,423 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $3,307,573 | 11,550 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $2,700,326 | 9,776 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $2,398,761 | 10,382 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,389,762 | 10,412 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,994,303 | 10,675 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,789,704 | 10,600 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,578,633 | 10,665 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,753,770 | 10,682 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,469,599 | 10,594 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||